Value of whole-body FDG PET in management of lung cancer
- 1 February 2003
- journal article
- review article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 17 (1) , 1-14
- https://doi.org/10.1007/bf02988253
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Intérêt de la tomographie à émission de positons au 18fluoro-déoxy-glucose dans la définition des champs de radiothérapie : exemple de la radiothérapie thoraciqueCancer/Radiothérapie, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Stellenwert der Positronen-Emissions-Tomographie mit 18-Fluor-Desoxyglukose (FDG-PET) in der Rezidivdiagnostik des BronchialkarzinomsPneumologie, 2000
- Evaluation of primary pulmonary carcinoid tumors using FDG PET.American Journal of Roentgenology, 1998
- Localized form of bronchioloalveolar carcinoma: FDG PET findings.American Journal of Roentgenology, 1998
- Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Rapid rise in FDG uptake in an irradiated human tumour xenograftEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinomaAnnals of Nuclear Medicine, 1996
- The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor modelsNuclear Medicine and Biology, 1996
- Growth factors, mitogens, oncogenes and the regulation of glucose transportCellular Signalling, 1993